PTO Form 1581 (Rev 4/2000) |
OMB Control #0651-0009 (Exp. 06/30/2005) |
Extension Statement of Use Filing
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
76249760 |
LAW OFFICE ASSIGNED |
LAW OFFICE 115 |
MARK SECTION |
MARK |
DRAXXIN |
OWNER SECTION (no change) |
ATTORNEY SECTION |
NAME |
Richard A. Friedman |
DOCKET NUMBER |
AHG/US/DRAXX |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
KEEP EXISTING GOODS AND/OR SERVICES |
YES |
EXTENSION SECTION |
EXTENSION NUMBER |
4 |
ONGOING EFFORT |
The product on which Applicant intends to use this mark cannot be marketed at present because ongoing clinical development and market research is continuing. |
ALLOWANCE MAIL DATE |
10/01/2002 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT |
150 |
TOTAL AMOUNT |
150 |
SIGNATURE SECTION |
SIGNATURE |
/Sudipta Rao/ |
SIGNATORY NAME |
SUDIPTA RAO |
SIGNATORY DATE |
09/27/2004 |
SIGNATORY POSITION |
TRADEMARK COUNSEL |
FILING INFORMATION |
SUBMIT DATE |
Mon Sep 27 15:33:08 EDT 2004 |
TEAS STAMP |
USPTO/ESU-XXX.XX.XXX.X-20
040927153308467098-762497
60-2006998608ecf6897a6f7e
1362563bcd3-DA-117-200409
27145032442176 |
PTO Form 1581 (Rev 4/2000) |
OMB Control #0651-0009 (Exp. 06/30/2005) |
Trademark/Service Mark Extension for Filing a Statement of Use
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: DRAXXIN
SERIAL NUMBER: 76249760
The applicant, Pfizer Inc., residing at 235 East 42nd Street , New York, NY US 10017, requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this
application. The Notice of Allowance mailing date was 10/01/2002.
For International Class: 005, the applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of
the goods and/or services listed in the Notice of Allowance, or as subsequently modified.
This is the fourth extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by
the extension request: The product on which Applicant intends to use this mark cannot be marketed at present because ongoing clinical development and market research is continuing..
The applicant hereby appoints Richard A. Friedman to submit this Request for Extension of Time to File a Statement of Use on behalf of the applicant. The attorney docket/reference number is
AHG/US/DRAXX.
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signature: /Sudipta Rao/ Date: 09/27/2004
Signatory's Name: SUDIPTA RAO
Signatory's Position: TRADEMARK COUNSEL
RAM Sale Number: 117
RAM Accounting Date: 09/28/2004
Serial Number: 76249760
Internet Transmission Date: Mon Sep 27 15:33:08 EDT 2004
TEAS Stamp: USPTO/ESU-XXX.XX.XXX.X-20040927153308467
098-76249760-2006998608ecf6897a6f7e13625
63bcd3-DA-117-20040927145032442176
Go Back